Bath & Body Works (BBWI) EBIT Margin (2009 - 2026)
Bath & Body Works' (BBWI) quarterly EBIT Margin came in at 14.27% in Q3 2026, up 413.0% year-over-year from 2.78% in Q3 2025, and down 35.12% quarter-over-quarter from 21.99% in Q1 2026.
Analysis
Bath & Body Works (BBWI) EBIT Margin (2009 - 2026) Analysis & Trends
Bath & Body Works (BBWI) has reported EBIT Margin for 18 consecutive years, with 14.27% the latest figure, recorded in Q3 2026.
- On a quarterly basis, EBIT Margin rose 413.0% year-over-year to 14.27% in Q3 2026; TTM through Aug 2026 was 15.35%, a 177.0% decrease from a year earlier, with the FY2026 full-year figure at 15.44%, down 188.0% from the prior year.
- EBIT Margin was 14.27% for Q3 2026 at Bath & Body Works, down from 21.99% in the prior quarter.
- Over five years, EBIT Margin peaked at 29.04% in Q1 2022 and troughed at 10.1% in Q4 2025.
- A 5-year average of 16.45% and a median of 14.21% in 2023 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin tumbled 1174 bps in 2022 and surged 413 bps in 2026, its largest moves.
- Over 5 years, EBIT Margin stood at 12.59% in 2022, then grew by 12 bps to 14.15% in 2023, then fell by 4 bps to 13.54% in 2024, then decreased by 25 bps to 10.1% in 2025, then jumped by 41 bps to 14.27% in 2026.
- The last three EBIT Margin figures came in at 14.27% (Q3 2026), 21.99% (Q1 2026), and 10.1% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.36 Bn | 68.99 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 34.27 Bn | 33.16 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 32.95 Bn | 31.99 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.76 Bn | 2.97 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.33 Bn | 2.27 Bn | - | - |
| 6 | Perrigo | 1.97 Bn | 1.57 Bn | 313.90 Mn | 2.30% |
| 7 | Herbalife | 1.27 Bn | 896.04 Mn | 1.03 Bn | 9.67% |
| 8 | Edgewell Personal Care | 1.23 Bn | 837.00 Mn | 242.50 Mn | 4.39% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 607.93 Mn | 502.04 Mn | 40.36 Mn | 11.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 1, 2026 | 14.27% |
| Jan 31, 2026 | 21.99% |
| Nov 1, 2025 | 10.10% |
| Aug 2, 2025 | 10.14% |
| May 3, 2025 | 14.68% |
| Feb 1, 2025 | 24.33% |
| Nov 2, 2024 | 13.54% |
| Aug 3, 2024 | 11.99% |
| May 4, 2024 | 13.51% |
| Feb 3, 2024 | 23.90% |
| Oct 28, 2023 | 14.15% |
| Jul 29, 2023 | 12.06% |
| Apr 29, 2023 | 12.97% |
| Jan 28, 2023 | 22.60% |
| Oct 29, 2022 | 12.59% |
| Jul 30, 2022 | 14.96% |
| Apr 30, 2022 | 19.31% |
| Jan 29, 2022 | 29.04% |
| Oct 30, 2021 | 24.33% |
| Jul 31, 2021 | 22.54% |